A delicate balance: IP rights and the public interest
The COVID-19 pandemic continues to take a heavy toll on families, communities, and nations the world over. As the virus spreads, companies and nations are racing to build vaccines and drugs to benefit society at large and, of course, tap a business opportunity. As the vaccine trials reach stage II and III, the plan for…